HBI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Harvard Bioscience Inc

Watchlist Manager

Watchlist

Price: 4.08 EUR Market Closed

Market Cap: €177.2m

H	Harvard Bioscience Inc F:HBI	US
	F5 Inc NASDAQ:FFIV	US
	Carnival PLC LSE:CCL	UK
B	Basf Se MIL:BASF	DE
T	Trimble Inc F:TB5	US

Profitability Summary

Harvard Bioscience Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

58%

Strong 3Y Average Gross Margin

58%

Gross Margin is Increasing

55% > 58%

Negative Operating Margin

-1%

Negative 3Y Average Operating Margin

-3%

Operating Margin is Increasing

-2% > -1%

Negative Net Margin

-66%

Negative 3Y Average Net Margin

-28%

Declining Net Margin

-5% > -66%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

6% > 6%

Negative ROE

-147%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2%

ROIC is Increasing

-1% > 0%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.